Tiziana Life Sciences Ltd SEC filings TLSA
Tiziana Life Sciences Ltd has 492 filings in SEC EDGAR's recent list, going back to Nov 30, 2017. Its latest annual report, Form 20-F, was filed on May 1, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Notification of late filing | Apr 30, 2026 | Dec 31, 2025 |
| AW | Withdrawal of amendment | Jan 22, 2026 | — |
| NT 20-F | Notification of late filing | Apr 30, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Mar 27, 2025 | — |
| CORRESP | Letter to the SEC | Mar 27, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2025 | — |
| NT 20-F | Notification of late filing | Apr 30, 2024 | Dec 31, 2023 |
| NT 20-F | Notification of late filing | Apr 29, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Mar 3, 2022 | — |
| CORRESP | Letter to the SEC | Mar 1, 2022 | — |
| 8-K12B | Current report | Oct 21, 2021 | Oct 20, 2021 |
| 25-NSE | Delisting notice | Oct 20, 2021 | — |
| NT 20-F | Notification of late filing | Apr 30, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Feb 1, 2021 | — |
| NT 20-F | Form nt 20-f | Jun 15, 2020 | Dec 31, 2019 |
| EFFECT | Filing | Feb 6, 2020 | — |
| CORRESP | Letter to the SEC | Feb 4, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2020 | — |
| RW | Registration withdrawal request | Oct 22, 2019 | — |
| DRS | Filing | Jul 17, 2019 | — |
| EFFECT | Filing | Nov 19, 2018 | — |
| CORRESP | Letter to the SEC | Nov 19, 2018 | — |
| CORRESP | Letter to the SEC | Nov 19, 2018 | — |
| EFFECT | Filing | Nov 9, 2018 | — |
| EFFECT | Filing | Nov 9, 2018 | — |
| CORRESP | Letter to the SEC | Nov 9, 2018 | — |
| CORRESP | Letter to the SEC | Nov 9, 2018 | — |
| CORRESP | Letter to the SEC | Nov 7, 2018 | — |
| CORRESP | Letter to the SEC | Nov 7, 2018 | — |
| CORRESP | Letter to the SEC | Nov 7, 2018 | — |
| CORRESP | Letter to the SEC | Nov 7, 2018 | — |
| CORRESP | Letter to the SEC | Nov 5, 2018 | — |
| CORRESP | Letter to the SEC | Nov 5, 2018 | — |
| CORRESP | Letter to the SEC | Nov 2, 2018 | — |
| CORRESP | Letter to the SEC | Nov 2, 2018 | — |
| CERT | Filing | Nov 1, 2018 | — |
| CORRESP | Letter to the SEC | Oct 30, 2018 | — |
| CORRESP | Letter to the SEC | Oct 30, 2018 | — |
| 8-A12B | For registration of certain classes of securities | Oct 30, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2018 | — |
| CORRESP | Letter to the SEC | Oct 23, 2018 | — |
| CORRESP | Letter to the SEC | Oct 18, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2018 | — |
| CORRESP | Letter to the SEC | Aug 31, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2018 | — |
| UPLOAD | Letter from the SEC | May 24, 2018 | — |
| DRSLTR | Filing | May 10, 2018 | — |
| DRS/A | Filing | May 10, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2018 | — |
| DRS/A | Filing | Feb 27, 2018 | — |
| DRS/A | Filing | Feb 27, 2018 | — |
| DRS/A | Filing | Feb 27, 2018 | — |
| DRS | Filing | Feb 27, 2018 | — |
| DRSLTR | Filing | Feb 26, 2018 | — |
| DRSLTR | Filing | Feb 26, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2018 | — |
| DRS/A | Filing | Feb 9, 2018 | — |
| DRS | Filing | Feb 9, 2018 | — |
| DRS/A | Filing | Feb 8, 2018 | — |
| DRSLTR | Filing | Feb 8, 2018 | — |
| DRS | Filing | Feb 8, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2018 | — |
| DRS/A | Filing | Dec 22, 2017 | — |
| DRS | Filing | Dec 22, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2017 | — |
| DRS | Filing | Nov 30, 2017 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Bermuda
- Headquarters
- London, England, United Kingdom
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723069
- Former names
- Tiziana Life Sciences plc (until Oct 21, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.